Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Muller

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|March 5, 2009
Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitorHon-Wah Man, Peter Schafer, Lu Min Wong, et al.
The Journal of Experimental Medicine|September 7, 2000
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptorL S Park, U Martin, K Garka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 15, 2024
Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne Expanded Clinical StudyLenard Conradi, Sebastian Ludwig, Paul Sorajja, et al.
British Journal of Pharmacology|January 7, 2010
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasisP H Schafer, A Parton, A K Gandhi, et al.
Cancer Research|January 20, 2007
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cellsDominique Verhelle, Laura G Corral, Kevin Wong, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1996
Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplastyP A Gurbel, F I Navetta, E R Bates, et al.
Clinical Breast Cancer|May 17, 2011
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trialPaul Hamberg, Monique M E M Bos, Hans J J Braun, et al.
Plos One|February 23, 2010
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsBrian B Tuch, Rebecca R Laborde, Xing Xu, et al.
Clinical Colorectal Cancer|February 21, 2019
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer GroupJohannes J M Kwakman, Erik van Werkhoven, Lieke H J Simkens, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|March 5, 2009
Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitorHon-Wah Man, Peter Schafer, Lu Min Wong, et al.
The Journal of Experimental Medicine|September 7, 2000
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptorL S Park, U Martin, K Garka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 15, 2024
Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne Expanded Clinical StudyLenard Conradi, Sebastian Ludwig, Paul Sorajja, et al.
British Journal of Pharmacology|January 7, 2010
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasisP H Schafer, A Parton, A K Gandhi, et al.
Cancer Research|January 20, 2007
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cellsDominique Verhelle, Laura G Corral, Kevin Wong, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1996
Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplastyP A Gurbel, F I Navetta, E R Bates, et al.
Clinical Breast Cancer|May 17, 2011
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trialPaul Hamberg, Monique M E M Bos, Hans J J Braun, et al.
Plos One|February 23, 2010
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsBrian B Tuch, Rebecca R Laborde, Xing Xu, et al.
Clinical Colorectal Cancer|February 21, 2019
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer GroupJohannes J M Kwakman, Erik van Werkhoven, Lieke H J Simkens, et al.
Pageof 28